NetworkNewsBreaks Archive - Page 1933 of 2081

WednesdayOct 04, 2017 11:48 am

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Apricus Biosciences, Inc. (NASDAQ: APRI)

SeeThruEquity issued a company update and price target of $4.30 on shares of Apricus Biosciences, Inc.’s (NASDAQ: APRI) stock. The analyst noted that the company has several upcoming catalysts, including the FDA decision for its Vitaros™ New Drug Application (NDA) resubmission. The company has already received its PDUFA date, which is February 17, 2018. If approved, Vitaros™ could be commercialized in the multi-billion-dollar erectile dysfunction (ED) market by the end of 2018. For more information, visit www.Apricusbio.com About Apricus Biosciences, Inc. Apricus Biosciences, Inc. (APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. Apricus has two product…

WednesdayOct 04, 2017 10:30 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on In Vitro Data Related to IGC-AD1

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent. “Based on our analysis of this and other previously announced compelling data, we are readying IGC-AD1 in a liquid formulation that will not cause inebriation,” Ram Mukunda, CEO of IGC, stated in the news release. “The initial commercialization will be through licensed medical cannabis dispensaries.” As…

WednesdayOct 04, 2017 10:04 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Names Dr. Richard Goulding as New Chief Executive Officer

PotNetwork Holding, Inc. (OTC: POTN) this morning announced, as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, its appointment of Richard Goulding, MD as its new chief executive officer. Per the news release, Goulding is expected to play a key role in directing PotNetwork’s endeavors to develop targeted formulas designed to deliver results for a diverse spectrum of challenges that can be aided by cannabidiol. “We believe, based on studies and reports, that CBD can contribute impressively to quality of life in those that are able to benefit from its…

WednesdayOct 04, 2017 9:33 am

NetworkNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Enters Collaboration and Licensing Agreement with Canntab Therapeutics

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) yesterday announced its entry into a collaboration and licensing agreement with Canntab Therapeutics Limited, developer of a patent-pending oral sustained release formulation for cannabinoids. Per the terms of the agreement, Emblem and Canntab will collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of this sustained release product, with Emblem receiving the exclusive right in Canada to Canntab’s patents and know-how for the purpose of developing and commercializing the innovative product under the Emblem brand. Manufacture of the sustained release product is expected to be completed by Emblem or Canntab following…

TuesdayOct 03, 2017 3:26 pm

NetworkNewsBreaks – EVIO, Inc. (EVIO) Begins Trading Under New OTCQB Ticker Symbol

Shares of EVIO’s (OTCQB: EVIO) stock began trading under the OTCQB ticker symbol 'EVIO' this morning, aligning the symbol with the company’s corporate name and EVIO lab brand. The company’s previous ticker symbol was SGBYD. Yesterday, Evio said the change had received approval from FINRA. ''We have now completed our corporate alignment for both customer and shareholders alike, this change helps us simplify our messaging to all of our stakeholders,' EVIO chief executive officer William Waldrop stated in the news release. To view the full press release, visit: http://nnw.fm/nKk3C About EVIO EVIO, Inc. is a life science company that provides…

TuesdayOct 03, 2017 3:24 pm

NetworkNewsBreaks – Mizuho Securities Reiterates ‘Buy’ Rating, Raises PT on Zogenix, Inc. (NASDAQ: ZGNX)

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and raised its price target from $28.00 to $51.00 on shares of Zogenix, Inc.’s (NASDAQ: ZGNX) stock. The report follows the company’s release of positive topline data for its pivotal phase 3 trial of ZX008 in Dravet Syndrome - Study 1. The study reached its primary endpoint, representing that 0.8 mg/kg/day of ZX008 as an adjunctive therapy is greater than a placebo in reducing mean monthly convulsive seizure frequency. The results also validate ZX008s mechanism of action involving Sig-1R receptor. The analyst noted that the efficacy results are better than expected,…

TuesdayOct 03, 2017 12:33 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 3, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CLSN 159.60% – News: Posts final clinical and translational research data from its OVATION Study KOOL 36.39% – News: Obtains U.S. patent covering cell separation method ETRM 14.19% – News: Acquires ReShape Medical, Inc. GEVO 10.05% – News: Expects to supply its renewable ATJ to the Virgin Australia Group EGAN 8.93% – News: Hosting eGain Digital+AI Day on December 5 RMGN 8.58% – News: Launches communication platform Korbyt™ MNGA 5.35% – News: Enters LOI…

TuesdayOct 03, 2017 12:33 pm

NetworkNewsBreaks – DOJA Cannabis Company (CSE: DOJA) Expands Production Capacity with Building Acquisition in Kelowna

DOJA Cannabis Company (CSE: DOJA) this morning said the courts have approved its offer to acquire a 22,580 sq.ft. building in Kelowna, British Columbia, out of bankruptcy protection. The closing of the acquisition is anticipated to take place on October 27. The company is also building a new facility which, upon completion, will raise DOJA’s corporate cannabis production capacity to more than 5,000 kg per year. “The acquisition is a game changer for DOJA, it allows us to expand our production capacity by almost 8 times, diversify our strain production, integrate a world class extraction lab and leverage the economies…

TuesdayOct 03, 2017 12:33 pm

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Cashes in on China’s Growing Cashless Trend

Within the global market, consumer trends are ever tending toward the utilization of mobile devices when making purchases and otherwise connecting with businesses—something seen particularly among Chinese consumers. Well aware of China’s cashless trend, Moxian, Inc. (NASDAQ: MOXC) is cashing in by serving the online-to-offline (O2O) market with its Moxian User App and Business App—both of which feature UnionPay’s payment gateway. An article further discussing this reads: “China has 1.3 billion residents. A large number of them use smartphones, and three-quarters of all online payments are sent through mobile accounts, according to analyst estimates. Spending through mobile payment platforms in…

TuesdayOct 03, 2017 12:31 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action. Lexaria intends to out-license this patented and proprietary technology, and the company has already applied this delivery technology to its line of products, which includes ViPova, Lexaria Energy and TurboCBD. An article further discussing this reads: “Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Apricus Biosciences, Inc. (NASDAQ: APRI)

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on In Vitro Data Related to IGC-AD1

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Names Dr. Richard Goulding as New Chief Executive Officer

NetworkNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Enters Collaboration and Licensing Agreement with Canntab Therapeutics

NetworkNewsBreaks – EVIO, Inc. (EVIO) Begins Trading Under New OTCQB Ticker Symbol

NetworkNewsBreaks – Mizuho Securities Reiterates ‘Buy’ Rating, Raises PT on Zogenix, Inc. (NASDAQ: ZGNX)

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 3, 2017

NetworkNewsBreaks – DOJA Cannabis Company (CSE: DOJA) Expands Production Capacity with Building Acquisition in Kelowna

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Cashes in on China’s Growing Cashless Trend

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search